Results 121 to 130 of about 491,703 (337)

Invasive disease‐free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor‐positive, HER2‐negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial

International Journal of Cancer, EarlyView.
What's New? Neoadjuvant chemotherapy (NACT) can be highly effective for patients with early‐stage breast cancer. Patients with hormone receptor‐positive (HRpos), HER2‐negative (HER2neg) breast cancer, however, may benefit less from NACT. Here, the authors investigated survival outcomes with adjuvant chemotherapy or NACT in a population of ...
Milena Beierlein, Lothar Häberle, Naiba Nabieva, Nicolai Maass, Bahriye Aktas, Sherko Kümmel, Christoph Thomssen, Christopher Wolf, Hans‐Christian Kolberg, Cosima Brucker, Wolfgang Janni, Peter Dall, Andreas Schneeweiss, Frederik Marme, Marc W. Sütterlin, Matthias Ruebner, Anna‐Katharin Theuser, Nadine M. Hofmann, Sybille Böhm, Katrin Almstedt, Sara Kellner, Paul Gass, Hans‐Joachim Lück, Alexander Hein, Sabine Schmatloch, Matthias Kalder, Christoph Uleer, Ingolf Juhasz‐Böss, Volker Hanf, Christian Jackisch, Volkmar Müller, Brigitte Rack, Erik Belleville, Diethelm Wallwiener, Achim Rody, Claudia Rauh, Chistian M. Bayer, Sabrina Uhrig, Hanna Huebner, Chloë Goossens, Sara Y. Brucker, Carolin C. Hack, Tanja N. Fehm, Peter A. Fasching   +43 more
wiley   +1 more source

Which dimensions of health‐related quality of life are altered in patients attending the different gynecologic oncology health care settings? [PDF]

, 2002
Giovanni Capelli, Rosa De Vincenzo, Alice Addamo, Francesco Bartolozzi, Nicola Braggio, Giovanni Scambia   +5 more
openalex   +1 more source

Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group study.

Gynecologic Oncology, 2020
W. Huh, W. Brady, P. Fracasso, D. Dizon, M. Powell, B. Monk, C. Leath, L. Landrum, E. Tanner, E. Crane, S. Ueda, M. McHale, C. Aghajanian   +12 more
semanticscholar   +1 more source

Targeted reactivation of the novel tumor suppressor DAPK1, an upstream regulator of p53, in high‐grade serous ovarian cancer by mRNA liposomes reduces viability and enhances drug sensitivity in preclinical models

Cancer Communications, EarlyView.
Monika Raab, Balázs Győrffy, Samuel Peña‐Llopis, Daniela Fietz, Monika Kressin, Margareta Kolaric, Matthias Ebert, Khayal Gasimli, Sven Becker, Mourad Sanhaji, Klaus Strebhardt   +10 more
wiley   +1 more source

The Fibrosis‐4 score is associated with overall mortality and severe haematological toxicity in older patients with cancer: Analysis of two prospective cohort studies

International Journal of Cancer, EarlyView.
What's New? Liver function decreases with age, affecting the metabolism of many chemotherapy drugs. For older cancer patients, however, a standardized liver status screening method is lacking. Here, Fibrosis‐4 (FIB‐4) score was investigated for its utility as a non‐invasive method in predicting treatment toxicity and mortality in cancer patients age 70
Victoire de Salins, Claudia Martinez‐Tapia, Pierre Gay, Antoine Morel, Michael Bringuier, Pascaline Boudou‐Rouquette, Lola Corsin, Amélie Aregui, Johanna Canovas, Pierre‐Emmanuel Rautou, Pierre Soubeyran, Carine Bellera, Florence Canoui‐Poitrine, Elena Paillaud, Johanne Poisson   +14 more
wiley   +1 more source

Continent urinary diversion in gynecologic oncology

, 1989
Manuel Peñalver, Darwich E. Bejany, Hervy E. Averette, Daniel Donato, Bernd‐Uwe Sevin, George M. Suarez   +5 more
openalex   +1 more source

Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis

Gynecologic Oncology, 2020
B. Pothuri, A. Secord, D. Armstrong, J. Chan, W. Huh, J. Kesterson, Joyce F. Liu, K. Moore, A. Fader, S. Westin, Wendel Naumann   +10 more
semanticscholar   +1 more source

Ascites of patients with solid tumors shows distinct inflammatory patterns

Cancer Communications, EarlyView.
Julia M. Berger, Martin Korpan, Carina Zierfuss, Katharina Syböck, Erwin Tomasich, Andreas Kienzle, Maria Koenig, Markus Kleinberger, Lynn Gottmann, Birgit Fendl, Cihan Ay, Johannes Pammer, Catharina Müller, Rudolf Oehler, Lorenz Balcar, Thomas Reiberger, Elisabeth S. Bergen, Barbara Niederdorfer, Matthias Preusser, Anna S. Berghoff   +19 more
wiley   +1 more source

Molecular analysis of the evolutionary history of endometrial and ovarian carcinoma in Lynch syndrome

International Journal of Cancer, EarlyView.
What's New? Lynch syndrome is a prevalent cause of hereditary gynecological cancers, but the timeline of molecular alterations preceding malignancy remains unclear. By studying consecutive surveillance specimens for up to 15 years before cancer diagnosis, the authors found that atypical endometrial hyperplasia was indistinguishable from endometrial and
Anni K. Kauppinen, Alisa P. Olkinuora, Jukka‐Pekka Mecklin, Päivi T. Peltomäki   +3 more
wiley   +1 more source

Integrative Analysis of Shared Pathogenic Genes and Potential Mechanisms in Gardnerella vaginalis and Persistent HPV16 Infection

Mediators of Inflammation
Bacterial vaginosis, often accompanied by Gardnerella vaginalis (GV) overgrowth, is associated with persistent high-risk human papillomavirus (HR-HPV) infection, particularly HPV16.
Ye Li, Yue Wang, Xianhua Liu, Huifeng Xue, Liying Wang, Maotong Zhang, Pengming Sun   +6 more
doaj   +1 more source